
    
      Development phase: Clinical trial Objectives: Assessment of functional and aesthetic outcome
      Methodology: Intervention study Sample size: 35+20+25 Main criteria for inclusion: Skull bone
      defect OR orbital floor fracture

      Investigational drug/treatment, dose and mode of administration: FRC implant Comparative
      drug(s)/placebo/treatment, dose and mode of administration: -

      Duration of treatment: 2 years of follow-up

      Assessments:

      Clinical outcome and radiologic assesment Functional and aesthetic outcome with Visual Analog
      Scale (VAS). Pain assessment with VAS.

      Statistical methods:

      Adequate statistical methods for publishing in international peer-reviewed journals.
    
  